WallStSmart

Lichen China Limited Class A Ordinary Shares (LICN)vsRB Global Inc. (RBA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

RB Global Inc. generates 19138% more annual revenue ($4.72B vs $24.52M). RBA leads profitability with a 9.6% profit margin vs -89.6%. RBA earns a higher WallStSmart Score of 61/100 (C+).

LICN

Avoid

26

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 9.00

RBA

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 6.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.35
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LICN.

RBAUndervalued (+62.9%)

Margin of Safety

+62.9%

Fair Value

$307.09

Current Price

$104.49

$202.60 discount

UndervaluedFair: $307.09Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LICN3 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

RBA2 strengths · Avg: 8.0/10
PEG RatioValuation
0.958/10

Growing faster than its price suggests

EPS GrowthGrowth
20.0%8/10

Earnings expanding 20.0% YoY

Areas to Watch

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$29.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-56.1%2/10

Revenue declined 56.1%

RBA3 concerns · Avg: 2.3/10
Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

P/E RatioValuation
50.1x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LICN

The strongest argument for LICN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : RBA

The strongest argument for RBA centers on PEG Ratio, EPS Growth. Revenue growth of 11.4% demonstrates continued momentum. PEG of 0.95 suggests the stock is reasonably priced for its growth.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : RBA

The primary concerns for RBA are Return on Equity, P/E Ratio, Altman Z-Score. A P/E of 50.1x leaves little room for execution misses.

Key Dynamics to Monitor

LICN profiles as a turnaround stock while RBA is a value play — different risk/reward profiles.

RBA carries more volatility with a beta of 0.56 — expect wider price swings.

RBA is growing revenue faster at 11.4% — sustainability is the question.

RBA generates stronger free cash flow (170M), providing more financial flexibility.

Bottom Line

RBA scores higher overall (61/100 vs 26/100) and 11.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

RB Global Inc.

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Ritchie Bros. The company is headquartered in Burnaby, Canada.

Want to dig deeper into these stocks?